Journal article
Rapid exacerbation of neuromyelitis optica after rituximab treatment
Journal of Clinical Neuroscience, Vol.26, pp.168-170
2016
Abstract
Studies have shown the efficacy of immunosuppressants against neuromyelitis optica (NMO). Rituximab is recommended as an off-label prescription to treat refractory NMO. However, we describe two such patients who were suboptimally responsive to rituximab and whose symptoms worsened after treatment. Our cautionary cases highlight that in a small proportion of patients with refractory NMO, rituximab may either fail or induce rapid relapse of NMO. This suggests we need to consider new treatment strategies for refractory NMO.
Details
- Title
- Rapid exacerbation of neuromyelitis optica after rituximab treatment
- Authors/Creators
- Y. Dai (Author/Creator) - Third Affiliated Hospital of Sun Yat-sen UniversityT. Lu (Author/Creator) - Third Affiliated Hospital of Sun Yat-sen UniversityY. Wang (Author/Creator) - Third Affiliated Hospital of Sun Yat-sen UniversityL. Fang (Author/Creator) - Third Affiliated Hospital of Sun Yat-sen UniversityR. Li (Author/Creator) - Third Affiliated Hospital of Sun Yat-sen UniversityA.G. Kermode (Author/Creator) - The University of Western AustraliaW. Qiu (Author/Creator) - Third Affiliated Hospital of Sun Yat-sen University
- Publication Details
- Journal of Clinical Neuroscience, Vol.26, pp.168-170
- Publisher
- Churchill Livingstone
- Identifiers
- 991005542583107891
- Copyright
- © 2016 Elsevier B.V.
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
30 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.203 Neuromuscular Disorders
- 1.203.147 Multiple Sclerosis
- Web Of Science research areas
- Clinical Neurology
- Neurosciences
- ESI research areas
- Neuroscience & Behavior